亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

隨州市紅旗化工有限公司  

醫藥原料醫藥中間體原料藥

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:閆先生
  • 電話:0722-3257386
  • 傳真:0722-3257381
  • QQ:1374834438
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 琥乙紅霉素 CAS號: 1264-62-6
琥乙紅霉素 CAS號: 1264-62-6
單價 面議對比
詢價 暫無
發貨 湖北隨州市付款后3天內
型號 1264-62-6
過期 長期有效
更新 2020-06-18 10:08
 
詳細信息

琥乙紅霉素
CAS號: 1264-62-6
中文同義詞: 紅霉素琥珀酸乙酯;琥乙紅霉素
英文名稱: Erythromycin ethylsuccinate
英文同義詞: ERYTHROMYCIN 2'-(ETHYL BUTANEDIOATE);ERYTHROMYCIN 2'-(ETHYL SUCCINATE);ERYTHROMYCIN ETHYLSUCCINATE;erythrocinethylsuccinate;erythromycin,mono(ethylsuccinate);erythromycin,mono(ethylsuccinate)(ester);erythroped;succinicacid,monoethylester,monoesterwitherythromycin
分子式: C43H75NO16
分子量: 862.05
EINECS號: 215-033-8
相關類別: Organics;Interferes with Protein SynthesisAntibiotics;A - KAntibiotics;Antibacterial;Antibiotics A to;Antibiotics A-FAntibiotics;Chemical Structure Class;Macrolides;Mechanism of Action;Spectrum of Activity
Mol文件: 1264-62-6.mol
熔點  219-224 C
安全信息
危險品標志  Xn,Xi
危險類別碼  42/43-36/37/38
安全說明  36-26
WGK Germany  2
RTECS號 WM9800000
毒害物質數據 1264-62-6(Hazardous Substances Data)
化學性質  白色結晶性粉末。
質量標準:CP2005  USP32  bp
含量:99%
用途  屬抗生素類藥,主要用于對青霉素耐藥的葡萄球菌感染
包裝:25KG/桶
 

©2025 隨州市紅旗化工有限公司 版權所有   技術支持:化工網   訪問量:31230  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |